imatinib mesylate has been researched along with Paraganglioma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bologna, G; Cama, A; D'Argenio, A; Esposito, DL; Florio, R; Guarnieri, S; Lanuti, P; Lotti, LV; Marchisio, M; Mariani-Costantini, R; Morgano, A; Opocher, G; Pantalone, MR; Paties, CT; Perconti, S; Prasad, SC; Rajasekhar, VK; Rossi, C; Sanna, M; Schiavi, F; Sheu, A; Söderberg-Nauclér, C; Taschin, E; Tramontana, L; Verginelli, F; Veronese, A; Vespa, S; Visone, R | 1 |
Belev, B; Boban, L; Boban, M; Cicek, S; Madzar, Z; Tomas, D; Zovak, M | 1 |
Amini, M; Campagna, D; Dei Tos, AP; Gasparotto, D; Maestro, R; Marzotto, A; Rossi, S; Scavina, P; Tiziano, FD; Toffolatti, L; Vitelli, CE | 1 |
Bobrzyk, M; Chronowska, J; Kukla, U; Madej, P; Okopień, B; Łabuzek, K | 1 |
Celestino, R; Faustino, A; Gouveia, A; Lima, J; Lopes, JM; Máximo, V; Soares, P; Vinagre, J | 1 |
Assie, G; Baudin, E; Bei, T; Boikos, SA; Briere, JJ; Carney, JA; Chompret, A; Ellison, JW; Eng, C; Ferrando, B; Gimenez-Roqueplo, AP; Matyakhina, L; McWhinney, SR; Muchow, M; Pacak, K; Pasini, B; Rustin, P; Stergiopoulos, S; Stratakis, CA | 1 |
6 other study(ies) available for imatinib mesylate and Paraganglioma
Article | Year |
---|---|
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.
Topics: Animals; Antineoplastic Agents; Cell Line; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Neural Stem Cells; Organogenesis; Paraganglioma; Primary Cell Culture; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Croatia; Developing Countries; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Paraganglioma; Piperazines; Pyrimidines; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2014 |
Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.
Topics: Abdominal Wall; Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease Progression; Drug Administration Schedule; Female; Gastrointestinal Stromal Tumors; Germ-Line Mutation; Humans; Imatinib Mesylate; Mutation; Paraganglioma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor alpha; Rectal Neoplasms; Succinate Dehydrogenase; Treatment Outcome | 2016 |
[Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Benzamides; Humans; Imatinib Mesylate; Indoles; Neovascularization, Pathologic; Paraganglioma; Pheochromocytoma; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib; Thalidomide | 2015 |
Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
Topics: Adult; Aged; Aged, 80 and over; Anoctamin-1; Base Sequence; Benzamides; Chloride Channels; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Molecular Sequence Data; Mutation; Neoplasm Proteins; Paraganglioma; Piperazines; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sequence Analysis, DNA; Succinate Dehydrogenase | 2013 |
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.
Topics: Adolescent; Adult; Alleles; Antineoplastic Agents; Base Sequence; Benzamides; Child; DNA Primers; DNA, Neoplasm; Female; Gastrointestinal Stromal Tumors; Genes, Dominant; Germ-Line Mutation; Heterozygote; Humans; Imatinib Mesylate; Iron-Sulfur Proteins; Loss of Heterozygosity; Male; Membrane Proteins; Neoplastic Syndromes, Hereditary; Paraganglioma; Piperazines; Pyrimidines; Succinate Dehydrogenase | 2008 |